About
Who We Are
Cardiovascular health
Board & executive
Careers
Events
Corporate Governance
Investor Information
Technology innovation
Our services
Our expertise
Our portfolio
Our markets
Point of Care
Cardiovascular
MedTech
Industrial
Cardiovascular products
EchoSolv™
Implicity
The Guardian
LUDO
Ventures
News
Contact
Hydrix to sell AI technology that improves identification of structural heart disease
Preserving your Myocardium
Hydrix announces USA FDA approval for the AngelMed Guardian® device
Experienced medical industry executive Vickie Edwards joins Hydrix
International symposium on the AngelMed Guardian sponsored by Hydrix Medical
Implantation of Next-Generation AngelMed Guardian® commences in US
Update on AngelMed Guardian implants in Singapore
First AngelMed Guardian implants in Asia-Pacific for Hydrix Medical
Introducing the AngelMed Guardian® a world first heart attack alert device
Angel Medical Systems partners with Hydrix to develop unique heart attack alert technology
Menu
Cookies help us deliver the best experience on our website. By using our website, you agree to the use of cookies.
Privacy Policy
Accept
